Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$623M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$615M |
| 3 |
IBM
IBM
|
+$448M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$368M |
| 5 |
Wells Fargo
WFC
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$791M |
| 2 |
EMC CORPORATION
EMC
|
+$736M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$501M |
| 4 |
Mondelez International
MDLZ
|
+$492M |
| 5 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$391M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.13% |
| 2 | Technology | 9.71% |
| 3 | Financials | 8.96% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6001
DELISTED
USMD HLDGS INC COM STK (DE)
USMD
| $8K | ﹤0.01% |
+352
| New | +$7.24K |
2016 Q3
0 quarters
|
|
|
SPHS
6002
DELISTED
Sophiris Bio, Inc.
SPHS
| $8K | ﹤0.01% |
2,700
+2,475
| +1,100% | +$9.31K |
2013 Q4
11 quarters
|
|
6003
DELISTED
CIFC LLC Common Shares
CIFC
| $8K | ﹤0.01% |
792
+350
| +79% | +$3.13K |
2013 Q4
11 quarters
|
|
|
GCVRZ
6004
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $8K | ﹤0.01% |
30,626
+2,370
| +8% | +$600 |
2013 Q2
13 quarters
|
|
|
JJT
6005
DELISTED
iPath Bloomberg Tin Subindex Total Return ETN due June 24, 2038
JJT
| $8K | ﹤0.01% |
215
| – | – |
2015 Q4
3 quarters
|
|
6006
China Automotive Systems
CAAS
$133M
| $7K | ﹤0.01% |
+1,700
| New | +$6.41K |
2016 Q3
0 quarters
|
|
6007
Alerian Energy Infrastructure ETF
ENFR
$547M
| $7K | ﹤0.01% |
289
| – | – |
2014 Q4
7 quarters
|
|
6008
Galectin Therapeutics
GALT
$372M
| $7K | ﹤0.01% |
6,621
-1,507
| -19% | -$2.68K |
2013 Q3
12 quarters
|
|
6009
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.07B
| $7K | ﹤0.01% |
105
| – | – |
2013 Q4
11 quarters
|
|
6010
NLI Holdings
NL
$324M
| $7K | ﹤0.01% |
+1,656
| New | +$5.86K |
2016 Q3
0 quarters
|
|
6011
Transact Technologies
TACT
$46.6M
| $7K | ﹤0.01% |
940
| – | – |
2015 Q4
3 quarters
|
|
6012
DELISTED
Reeds, Inc. Common Stock
REED
| $7K | ﹤0.01% |
38
+5
| +15% | +$744 |
2013 Q3
12 quarters
|
|
|
EVFM
6013
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $7K | ﹤0.01% |
69
-2
| -3% | -$183 |
2015 Q2
5 quarters
|
|
|
MJCO
6014
DELISTED
Majesco
MJCO
| $7K | ﹤0.01% |
1,563
+1,072
| +218% | +$5.67K |
2015 Q2
5 quarters
|
|
|
NVTR
6015
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $7K | ﹤0.01% |
953
-10,711
| -92% | -$73.6K |
2016 Q1
2 quarters
|
|
|
OTIV
6016
DELISTED
OTI On Track Innovations Ltd
OTIV
| $7K | ﹤0.01% |
7,000
-22,054
| -76% | -$24.8K |
2013 Q4
11 quarters
|
|
|
WMW
6017
DELISTED
ELEMENTS ETN MSTR Wide Moat FC TR
WMW
| $7K | ﹤0.01% |
284
| – | – |
2016 Q2
1 quarter
|
|
|
NRCIB
6018
DELISTED
National Research Corp Class B
NRCIB
| $7K | ﹤0.01% |
200
+150
| +300% | +$5.07K |
2013 Q2
13 quarters
|
|
6019
DELISTED
iPath Global Carbon ETN
GRN
| $7K | ﹤0.01% |
1,250
-1,812
| -59% | -$9.44K |
2015 Q4
3 quarters
|
|
|
CELGZ
6020
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $7K | ﹤0.01% |
6,689
| – | – |
2013 Q4
11 quarters
|
|
6021
Aurinia Pharmaceuticals
AUPH
$2.18B
| $6K | ﹤0.01% |
2,099
| – | – |
2014 Q3
8 quarters
|
|
6022
FG Communities Holdings Inc. Common Stock
FGC
$30.1M
| $6K | ﹤0.01% |
8
| – | – |
2015 Q1
6 quarters
|
|
6023
Schwab Fundamental US Small Company Index ETF
FNDA
$8.79B
| $6K | ﹤0.01% |
384
| – | – |
2016 Q2
1 quarter
|
|
6024
iBio
IBIO
$50.3M
| $6K | ﹤0.01% |
2
| – | – |
2014 Q4
7 quarters
|
|
6025
Intrepid Potash
IPI
$445M
| $6K | ﹤0.01% |
525
-1,536
| -75% | -$20.1K |
2013 Q2
13 quarters
|
|
Similar funds
Morgan Stanley's Q3 2016 Portfolio in Review
As of Q3 2016, Morgan Stanley held 6,800 positions worth $293B, up 5.8% from $277B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Morgan Stanley's Q3 2016 filing shows 189 new, 3,183 increased, 2,670 reduced and 222 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $791M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M.
- Morgan Stanley added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2016, an estimated $623M increase.
- Morgan Stanley's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $791M.
- Morgan Stanley fully exited EMC CORPORATION in Q3 2016, selling an estimated $736M.
- Morgan Stanley's ten largest holdings make up 13% of its $293B portfolio in Q3 2016.
- Morgan Stanley opened 189 new positions and closed 222 in Q3 2016.
- Morgan Stanley's portfolio value rose 5.8% quarter-over-quarter to $293B.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.